CME Group Inc (NASDAQ:CME) Director Jeffrey M. Bernacchi sold 1,501 shares of the business’s stock in a transaction that occurred on Thursday, November 30th. The stock was sold at an average price of $149.75, for a total value of $224,774.75. Following the transaction, the director now owns 60,194 shares in the company, valued at $9,014,051.50. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

CME Group Inc (NASDAQ CME) traded up $1.71 during mid-day trading on Thursday, hitting $149.54. 2,434,088 shares of the stock traded hands, compared to its average volume of 1,358,089. The stock has a market cap of $49,212.37, a price-to-earnings ratio of 30.36, a PEG ratio of 2.98 and a beta of 0.71. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 0.11. CME Group Inc has a 1 year low of $111.54 and a 1 year high of $151.85.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Thursday, October 26th. The financial services provider reported $1.19 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.16 by $0.03. The firm had revenue of $890.80 million for the quarter, compared to analyst estimates of $890.22 million. CME Group had a net margin of 40.94% and a return on equity of 7.89%. The business’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.05 EPS. sell-side analysts forecast that CME Group Inc will post 4.78 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 27th. Stockholders of record on Friday, December 8th will be given a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 1.77%. The ex-dividend date of this dividend is Thursday, December 7th. CME Group’s payout ratio is presently 59.86%.

Several research analysts have recently weighed in on the company. BidaskClub cut CME Group from a “buy” rating to a “hold” rating in a report on Wednesday, October 25th. Citigroup boosted their target price on CME Group from $138.00 to $155.00 and gave the stock a “buy” rating in a report on Thursday, October 19th. Royal Bank Of Canada boosted their target price on CME Group from $135.00 to $147.00 and gave the stock an “outperform” rating in a report on Monday, October 16th. Barclays boosted their target price on CME Group from $139.00 to $149.00 and gave the stock an “overweight” rating in a report on Tuesday, October 10th. Finally, Wells Fargo & Company boosted their target price on CME Group from $130.00 to $145.00 and gave the stock a “market perform” rating in a report on Wednesday, October 4th. One research analyst has rated the stock with a sell rating, four have given a hold rating and seven have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $141.75.

Several hedge funds have recently added to or reduced their stakes in the company. Honkamp Krueger Financial Services Inc. raised its position in shares of CME Group by 0.4% during the 2nd quarter. Honkamp Krueger Financial Services Inc. now owns 2,937 shares of the financial services provider’s stock valued at $368,000 after buying an additional 13 shares during the period. Hudock Capital Group LLC raised its position in shares of CME Group by 0.5% during the 2nd quarter. Hudock Capital Group LLC now owns 3,890 shares of the financial services provider’s stock valued at $487,000 after buying an additional 20 shares during the period. Ropes Wealth Advisors LLC raised its position in shares of CME Group by 0.4% during the 2nd quarter. Ropes Wealth Advisors LLC now owns 10,801 shares of the financial services provider’s stock valued at $1,353,000 after buying an additional 38 shares during the period. CAPROCK Group Inc. raised its position in shares of CME Group by 0.9% during the 2nd quarter. CAPROCK Group Inc. now owns 5,787 shares of the financial services provider’s stock valued at $725,000 after buying an additional 50 shares during the period. Finally, Pekin Singer Strauss Asset Management IL raised its position in shares of CME Group by 0.5% during the 2nd quarter. Pekin Singer Strauss Asset Management IL now owns 13,692 shares of the financial services provider’s stock valued at $1,715,000 after buying an additional 64 shares during the period. 83.08% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION WARNING: “CME Group Inc (CME) Director Jeffrey M. Bernacchi Sells 1,501 Shares” was posted by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another publication, it was illegally copied and reposted in violation of United States & international copyright laws. The original version of this piece of content can be read at https://www.americanbankingnews.com/2017/11/30/cme-group-inc-cme-director-jeffrey-m-bernacchi-sells-1501-shares.html.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.